drugset / Trial / NCT03678129
GABA Pathways in Autism Spectrum Disorder (ASD)
Non-randomizedParallel-groupDouble-blindBasic science
Summary
This study investigates the brain response to a single acute dose of a GABAa receptor acting drug (Benzodiazepine or positive allosteric modulator) compared to a single dose of placebo in adults with and without autism spectrum disorder.
Timeline
- Start
- 2018-12-07
- Primary completion
- 2025-06-27
- Completion
- 2025-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7325 | Small molecule | 10 mg | Oral |
| Subject | AZD7325 | Small molecule | 20 mg | Oral |
| Subject | Clobazam | Small molecule | 5 mg | — |